Compare Kava (KAVA) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kava vs Mira — how do they compare? Kava trades at Rp724.06 (market cap Rp784,32M, Rp166,4M 24h volume), while Mira trades at Rp700.06 (market cap Rp224,75M, Rp102,62M 24h volume). The key difference: Kava is far larger — about 3.5× Mira's market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while Kava's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Kava for 56 Days and Mira for 22 Days on average.
| KAVA | MIRA | |
|---|---|---|
Market Cap | Rp784,32M | Rp224,75M |
Volume (24h) | Rp166,4M | Rp102,62M |
Circulating Supply | 1,1B KAVA | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 56 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KAVA is currently trading at Rp725.54 with a market cap of Rp783.38M, showing bearish technical signals with 17 sell indicators versus 2 buy signals. The token is trading near its pivot point of Rp729, with immediate support at Rp716 and resistance at Rp740. Technical indicators show mixed signals with RSI_12 at 14.95 (oversold) while ADX readings above 50 indicate strong bearish momentum.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential oversold bounce from RSI_12 levels, while major risks include continued selling pressure and low trading volumes. Investors should monitor support at Rp716 for potential breakdown or bounce scenarios.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kava
KAVA is a cross-chain DeFi lending platform that allows users to borrow USDX stablecoins and deposit a variety of cryptocurrencies to begin earning a yield. Built on the Cosmos blockchain, Kava makes use of a collateralized debt position (CDP) system to ensure stablecoin loans are always sufficiently collateralized.
Read more on KAVA →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
